@article{412fc6d3021f418b93c8c2f087ec7da3,
title = "Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.",
author = "Kempen, \{John H.\} and Sapna Gangaputra and Ebenezer Daniel and Levy-Clarke, \{Grace A.\} and Nussenblatt, \{Robert B.\} and Rosenbaum, \{James T.\} and Suhler, \{Eric B.\} and Suhler, \{Eric B.\} and Thorne, \{Jennifer E.\} and Foster, \{C. Stephen\} and Jabs, \{Douglas A.\} and Jabs, \{Douglas A.\} and Helzlsouer, \{Kathy J.\} and Helzlsouer, \{Kathy J.\}",
note = "Focused evidence assessment. Management of ocular inflammatory diseases was revolutionized in the 1950's when the benefits of corticosteroid therapy were first reported. Unfortunately, in many of the most severe cases-where long-term use of moderate to high doses of systemic corticosteroids would be required to prevent vision loss-use of corticosteroids is constrained by substantial toxicity.",
year = "2008",
month = dec,
day = "1",
doi = "10.1016/J.AJO.2008.04.035",
language = "American English",
volume = "146",
journal = "American Journal of Ophthalmology",
issn = "1879-1891",
number = "6",
}